Zobrazeno 1 - 10
of 34
pro vyhledávání: '"L M, Rasmussen"'
Autor:
A. Sahafi, Y. Wang, C. L. M. Rasmussen, P. Bollen, G. Baatrup, V. Blanes-Vidal, J. Herp, E. S. Nadimi
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-10 (2022)
Abstract Gastrointestinal (GI) tract diseases are responsible for substantial morbidity and mortality worldwide, including colorectal cancer, which has shown a rising incidence among adults younger than 50. Although this could be alleviated by regula
Externí odkaz:
https://doaj.org/article/13b38d4446524593930973c426eba629
Autor:
L. B. Steffensen, J. Stubbe, J. S. Lindholt, H. C. Beck, M. Overgaard, M. Bloksgaard, F. Genovese, S. Holm Nielsen, M. L. T. Tha, S. K. Bang-Moeller, M. K. T. Hong Lin, J. H. Larsen, D. R. Hansen, G. T. Jones, M. J. Bown, M. A. Karsdal, L. M. Rasmussen
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-13 (2021)
Abstract Abdominal aortic aneurysm (AAA) is a complex disease which is incompletely accounted for. Basement membrane (BM) Collagen IV (COL4A1/A2) is abundant in the artery wall, and several lines of evidence indicate a protective role of baseline COL
Externí odkaz:
https://doaj.org/article/3d1b5c247947475dacbe108ba6ec5da2
Autor:
Pawel Stocki, Jaroslaw Szary, Mykhaylo Demydchuk, Leandra Northall, Charlotte L. M. Rasmussen, Diana Bahu Logan, Aziz Gauhar, Laura Thei, Shu-Fen Coker, Torben Moos, Frank S. Walsh, J. Lynn Rutkowski
Publikováno v:
Pharmaceutics, Vol 15, Iss 3, p 739 (2023)
Since the delivery of biologic drugs to the brain is greatly hampered by the existence of the blood–brain barrier (BBB), brain shuttles are being developed to enhance therapeutic efficacy. As we have previously shown, efficient and selective brain
Externí odkaz:
https://doaj.org/article/82000d2623a94836867f72035c2923dd
Autor:
Louise H. Jørgensen, Mia D. Sørensen, Mette M. Lauridsen, L. M. Rasmussen, Rose M. Alfiler, Vilde N. Iversen, Ove B. Schaffalitzky de Muckadell
Publikováno v:
Scandinavian Journal of Clinical and Laboratory Investigation. 82:261-266
We have established and describe two measurement procedures to diagnose possible zinc (Zn) deficiency; albumin-corrected Zn concentration and available free Zn-binding capacity. Reference intervals for both biomarkers were established in healthy adul
Autor:
S Hasific, K A Oevrehus, J S Lindholt, A Mejldal, D Dey, S Auscher, J Lambrechtsen, S Hosbond, D Alan, G Urbonaviciene, S Becker, L M Rasmussen, A P Diederichsen
Publikováno v:
European Heart Journal. 43
Background Coronary artery calcification (CAC) and especially progression in CAC is a strong predictor of acute myocardial infarction (AMI) and cardiovascular mortality [1]. Observational studies suggest a protective role of vitamin K2 in the develop
Autor:
S Hansen, A Von Buelow, M B Soendergaard, L M Rasmussen, C R Johnsen, T S Ingebrigtsen, K E J Haakansson, K D Assing, S L Johansson, J Schmid, A Bjerrum, O Hilberg, C Ulrik, C M Porsbjerg
Publikováno v:
05.01 - Airway pharmacology and treatment.
Autor:
Leandra Northall, Charlotte L M Rasmussen, Laura Thei, Mykhaylo Demydchuk, Aziz Gauhar, Diana Bahu Logan, Frank S. Walsh, Torben Moos, J Lynn Rutkowski, Pawel Stocki, Jaroslaw Szary
Publikováno v:
Stocki, P, Szary, J, Rasmussen, C L M, Demydchuk, M, Northall, L, Logan, D B, Gauhar, A, Thei, L, Moos, T, Walsh, F S & Rutkowski, J L 2021, ' Blood-brain barrier transport using a high affinity, brain-selective VNAR antibody targeting transferrin receptor 1 ', F A S E B Journal, vol. 35, no. 2, e21172 . https://doi.org/10.1096/fj.202001787R
Transfer across the blood-brain barrier (BBB) remains a significant hurdle for the development of biopharmaceuticals with therapeutic effects within the central nervous system. We established a functional selection method to identify high affinity si
Autor:
M. Heisterkamp, S. Titze, J. Lorenzen, K.-U. Eckardt, A. Koettgen, J. T. Kielstein, A. Bouquegneau, E. Vidal-Petiot, F. Vrtovsnik, E. Cavalier, J. M. Krzesinski, M. Flamant, P. Delanaye, L. Anguiano, M. Riera, J. Pascual, C. Barrios, A. Betriu, J. M. Valdivielso, E. Fernandez, M. J. Soler, M.-A. Denys, A. Viaene, A.-S. Goessaert, J. Delanghe, K. Everaert, Y. S. Kim, M. J. Choi, J. Y. Deok, S. G. Kim, S. Bevc, N. Hojs, R. Hojs, R. Ekart, M. Gorenjak, L. Puklavec, M. Piskunowicz, L. Hofmann, E. Zurcher, I. Bassi, C. Zweiacker, M. Stuber, K. Narkiewicz, B. Vogt, M. Burnier, M. Pruijm, E. Rusu, D. Zilisteanu, T. Atasie, A. Circiumaru, F. Carstea, M. Ecobici, M. Rosca, C. Tanase, S. Mihai, M. Voiculescu, Y. D. Jeon, M. Polenakovic, N. Pop-Jordanova, S.-C. Hung, D.-C. Tarng, L. Tuta, A. Stanigut, P. Mesiano, C. Rollino, M. Ferro, G. Beltrame, C. Massara, G. Quattrocchio, M. Borca, M. Bazzan, D. Roccatello, A. Maksudova, L. I. Urasaeva, T. N. Khalfina, H. Tekce, B. Kin Tekce, G. Aktas, A. Alcelik, E. Sengul, J. Lindic, D. Purg, J. Skamen, M. Krsnik, A. Skoberne, J. Pajek, R. Kveder, A. Bren, D. Kovac, G. Delgado, C. Drechsler, C. Wanner, K. Blouin, S. Pilz, A. Tomaschitz, M. E. Kleber, C. Willmes, V. Krane, W. Marz, E. Ritz, W. H. Van Gilst, P. Van Der Harst, R. A. De Boer, A. Scholze, L. Petersen, B. Hocher, L. M. Rasmussen, M. Tepel, E. A. De Paula, C. P. Vanelli, M. S. Caminhas, B. C. Soares, F. A. Bassoli, D. M. N. Da Costa, C. M. M. Lanna, A. G. S. Galil, F. A. B. Colugnati, M. B. Costa, M. G. Bastos, R. B. De Paula, D. Santoro, Z. Zappulla, A. Alibrandi, M. Tomasello Andulajevic, M. Licari, S. Baldari, M. Buemi, V. Cernaro, A. Campenni, N. Pallet, S. Chauvet, C. Levi, V. Meas-Yedid, P. Beaune, E. Thevet, A. Karras, S. Santos, J. Malheiro, A. Campos, S. Pedroso, J. Santos, A. Cabrita, M. M. Mayor, R. Ayala, C. Ramos, S. Franco, R. Guillen, J. S. Kim, J. W. Yang, B. G. Han, S. O. Choi, M.-N. Tudor, M. F. Navajas Martinez, C. Vaduva, D. T. Maria, E. Mota, R. Clari, E. Mongilardi, F. N. Vigotti, V. Consiglio, S. Scognamiglio, M. Nazha, S. Roggero, A. Piga, G. Piccoli, P. Mukhopadhyay, K. Patar, N. Chaterjee, K. Ganguly
Publikováno v:
Nephrology Dialysis Transplantation. 29:iii114-iii123
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Journal of endocrinological investigation. 36(7)
Increased osteoprotegerin (OPG) levels are associated with increased cardiovascular risk and decreased bone resorption. Pioglitazone treatment reduces the inflammatory state but may decrease bone mineral density (BMD). OPG levels during pioglitazone